How many stocks are there of Almirall?
The current number of stocks of Almirall is 196.99 M undefined.
Almirall Stocks 2024
Almirall Stocks
196.99 M
Ticker
ALM.MC
ISIN
ES0157097017
WKN
A0MU8Y
In 2024, Almirall had 196.99 M outstanding stocks, a 0% change from the 196.99 M stocks in the previous year.
The Almirall Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2028e | 196.99 |
| 2027e | 196.99 |
| 2026e | 196.99 |
| 2025e | 196.99 |
| 2024e | 196.99 |
| 2023 | 196.99 |
| 2022 | 184.53 |
| 2021 | 184.41 |
| 2020 | 183.27 |
| 2019 | 182.74 |
| 2018 | 183.5 |
| 2017 | 181.3 |
| 2016 | 181.3 |
| 2015 | 177.19 |
| 2014 | 173.6 |
| 2013 | 173.7 |
| 2012 | 171.8 |
| 2011 | 175.5 |
| 2010 | 175.5 |
| 2009 | 175.5 |
| 2008 | 175.5 |
| 2007 | 171.5 |
| 2006 | 183.9 |
| 2005 | 183.9 |
| 2004 | 183.9 |
Almirall shares outstanding ES0157097017 · A0MU8Y
The number of shares was Almirall in 2023 — This indicates how many shares 196.992 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Almirall earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Almirall's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Almirall’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Almirall's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 183.9 M Aktien |
| 2005 | 183.9 M Aktien |
| 2006 | 183.9 M Aktien |
| 2007 | 171.5 M Aktien |
| 2008 | 175.5 M Aktien |
| 2009 | 175.5 M Aktien |
| 2010 | 175.5 M Aktien |
| 2011 | 175.5 M Aktien |
| 2012 | 171.8 M Aktien |
| 2013 | 173.7 M Aktien |
| 2014 | 173.6 M Aktien |
| 2015 | 177.19 M Aktien |
| 2016 | 181.3 M Aktien |
| 2017 | 181.3 M Aktien |
| 2018 | 183.5 M Aktien |
| 2019 | 182.74 M Aktien |
| 2020 | 183.27 M Aktien |
| 2021 | 184.41 M Aktien |
| 2022 | 184.53 M Aktien |
| 2023 | 196.99 M Aktien |
| 2024e | 196.99 M Aktien |
| 2025e | 196.99 M Aktien |
| 2026e | 196.99 M Aktien |
| 2027e | 196.99 M Aktien |
| 2028e | 196.99 M Aktien |
Almirall Aktienanalyse
What does Almirall do?
The company Almirall SA is a globally operating pharmaceutical company headquartered in Barcelona, Spain. Founded in 1943 by Antonio Gallardo Ballart, the company has since become one of the leading companies in the field of dermatology and respiratory diseases. Almirall specializes in the development, manufacturing, and marketing of medications used in the treatment of skin conditions such as psoriasis or eczema, as well as respiratory diseases such as asthma or chronic bronchitis. The company focuses on close collaboration with doctors and patients to achieve the best possible therapeutic success. Almirall's business model is based on collaboration with other pharmaceutical companies to develop and bring innovative medications to the market. The company has its own research and development departments and also conducts clinical trials to test the safety and efficacy of new medications. Additionally, Almirall operates its own network of distribution and marketing partners to distribute its products worldwide. Almirall is organized into three divisions: dermatology, respiratory diseases, and other therapeutic areas. The dermatology division includes the development and marketing of medications for the treatment of skin conditions such as psoriasis and eczema. Some examples of products in this division are Skilarence, a medication for the treatment of moderate to severe psoriasis, and Kigozi, a topical medication for the treatment of atopic dermatitis. The respiratory diseases division includes the development and marketing of medications for the treatment of asthma and chronic bronchitis. The company offers a wide range of medications in this area that can be used in inhalation or tablet therapy. Some of the well-known products in this division are Alvesco, an inhaled corticosteroid for the treatment of asthma, and Ebastel, a medication for the treatment of allergic reactions. In other therapeutic areas, Almirall is involved in the development of new medications for the treatment of diseases such as ulcerative colitis or schizophrenia. For example, the company has developed Sativex, a cannabis-based medication for the treatment of multiple sclerosis-related spasticity, which is already approved in several countries. Throughout its history, Almirall has received numerous awards and recognition, including for the development of innovative medications and its work in the field of sustainability and corporate social responsibility. Through its commitment to research and development and collaboration with other pharmaceutical companies, Almirall will continue to play an important role in the global pharmaceutical industry market. Almirall ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Almirall's Shares Outstanding
Almirall's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Almirall’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Almirall’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Almirall’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Almirall stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Almirall are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Almirall evolved in recent years?
The number of shares of Almirall has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Almirall as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Almirall?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Almirall pay?
Over the past 12 months, Almirall paid a dividend of 0.18 EUR . This corresponds to a dividend yield of about 2.04 %. For the coming 12 months, Almirall is expected to pay a dividend of 0.18 EUR.
What is the dividend yield of Almirall?
The current dividend yield of Almirall is 2.04 %.
When does Almirall pay dividends?
Almirall pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Almirall?
Almirall paid dividends every year for the past 14 years.
What is the dividend of Almirall?
For the upcoming 12 months, dividends amounting to 0.18 EUR are expected. This corresponds to a dividend yield of 2.01 %.
In which sector is Almirall located?
Almirall is assigned to the 'Health' sector.
Wann musste ich die Aktien von Almirall kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Almirall from 6/12/2024 amounting to 0.184 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.
When did Almirall pay the last dividend?
The last dividend was paid out on 6/12/2024.
What was the dividend of Almirall in the year 2023?
In the year 2023, Almirall distributed 0.186 EUR as dividends.
In which currency does Almirall pay out the dividend?
The dividends of Almirall are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Almirall
Our stock analysis for Almirall Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Almirall Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
